Revised: 2 October 2019

Information for Industry

Guidance on the regulatory processes for suppliers in New Zealand of medicines and medical devices.

Industry News

Date Type Title
19/11/2020CommitteesAgenda for the 184th Medicines Adverse Reactions Committee meeting - 3 December 2020
18/11/2020CommitteesMedicines Classification Committee - Dates and Deadlines
6/11/2020NoticesMedsafe Performance Statistics for 2018 - July 2020
6/11/2020Alert CommunicationUpdate to Original Communication - Important updates to clozapine data sheets and monitoring during covid-19 pandemic
5/11/2020NoticesCodeine-containing medicines have now been reclassified
The recommendations from the 59th MCC meeting has been gazetted today
3/11/2020NoticesNotice of Medsafe Office Closure Christmas/New Year 2020/2021
30/10/2020Monitoring CommunicationUPDATE: Concern reported with the use of NovoRapid® Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
23/10/2020CommitteesComments on agenda for 65th Medicines Classificaton Committee meeting
23/10/2020Monitoring CommunicationConcern reported with the use of NovoRapid® Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
22/10/2020Media ReleaseCodeine-containing medicines to be reclassified
14/10/2020CommitteesAgenda for the 65th Medicines Classification Committee meeting Please note there have been some changes to the agenda relating to removing New Chemical Entities that were classified at the 64th meeting of the MCC and clarification of the agenda item Harmonisation of the NZ and Australian schedules for noting

If you have a query that is not answered by the information in this section please contact us at askmedsafe@health.govt.nz

Show menus
0 1 2 4 5 6 7 9 [ /